Trend
DailyUptrend (confirmed)
4 hourAscending Triangle
1 hourExpanding
15 minLeaning Bullish
5 minBullish
Daily trend turns down below $13.71
Key levels
Resistance$14.57
Resistance$14.13
Support$13.88
Support$13.76
Latest news & SEC filings
No headlines in the last 90 days.
Organon is a healthcare company that sells prescription medicines in women's health and general medicines. Its women's health products cover contraception and fertility, while its general medicines include biosimilars for immunology and oncology plus older brands in cardiovascular, respiratory, dermatology and pain care. It reaches customers through wholesale distributors, pharmacies, clinics, public health bodies and managed care organizations across more than 140 countries, with manufacturing sites in Europe, Latin America and Asia.
Based on the company's 10-K filed Feb 24, 2026.
NYSE · Healthcare
SEPT Low Target
$11.90
SEPT Mid Target
$14.00
SEPT High Target
$16.10
Analyst Consensus
$14.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OGN.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$21.20
38
Moat Score
NONE
5/9
Piotroski Score
1.0
Altman Z-Score
Insider Signal
NEUTRAL
1 buys / 2 sells (90d)
Congress Signal
SELLING
0 buys / 5 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Arjona Ferreira Juan Camilo | officer | Buy | 6,447 | - | Nov 7, 2026 |
| Arjona Ferreira Juan Camilo | officer | Sale | 2,314 | $32K | Nov 7, 2026 |
| Drinane Juliana Papa | officer | Buy | 3,626 | - | Nov 7, 2026 |
| Drinane Juliana Papa | officer | Sale | 1,242 | $17K | Nov 7, 2026 |
| Holzbaur Lynette | officer | Buy | 2,418 | - | Nov 7, 2026 |
| Holzbaur Lynette | officer | Sale | 689 | $10K | Nov 7, 2026 |
| Holzbaur Lynette | officer | Buy | 3,038 | - | Nov 5, 2026 |
| Holzbaur Lynette | officer | Sale | 866 | $12K | Nov 5, 2026 |
| Arjona Ferreira Juan Camilo | officer | Buy | 11,519 | - | Aug 11, 2026 |
| Arjona Ferreira Juan Camilo | officer | Sale | 4,134 | $56K | Aug 11, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-2.9%
3yr Revenue CAGR
0.2%
EPS Growth YoY
-78.38%
FCF Growth YoY
-29.6%
Revenue Trend
SLOWING
SEPT Investing tracks real-time dark pool institutional trades for OGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:44 | $13.90 | 178,989 | $$2.5M | BUY |
| 21:00:33 | $13.90 | 5,266 | $$73K | BUY |
| 21:00:33 | $13.90 | 2,683 | $$37K | BUY |
| 21:00:33 | $13.90 | 23,100 | $$321K | BUY |
| 21:00:31 | $13.90 | 1,600 | $$22K | BUY |
5 dark pool trades shown · $$2.9M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for OGN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $15 | Jan 21 | 434 | $$45 | 9 | SWEEP |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Organon & Co. (OGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Organon & Co. (OGN) is at $13.90, up 0.00% (+$0.00) at the Nov 13, 2026 close.
The average analyst price target for OGN is $14.00, ranging from $14 to $14, based on 2 analysts. Latest: BNP Paribas downgrade on Apr 29, 2026.
Analyst ratings for OGN: 0 Buy, 3 Hold, 1 Sell — consensus Hold.
OGN last reported on Jul 31, 2026: EPS $0.85 vs $0.85 expected — in line.
OGN trades at a P/E of 17.7 vs a Healthcare average of 18.4.
Yes. OGN's dividend yield is 4.73%.
Organon & Co. reported $8.6B of debt and $1.1B of cash (Jun 30, 2026).
Support: $13.88, $13.76, $13.63. Resistance: $14.13, $14.57, $14.71.
Insider activity: NEUTRAL, 1 buys and 2 sells in the last 90 days.